tga
The High Cost of Relief: How Medical Cannabis Pricing Leaves Patients Behind
As health bodies call for crackdown on rogue operators, affordability crisis goes unaddressed.
tga
As health bodies call for crackdown on rogue operators, affordability crisis goes unaddressed.
tga
The Reviewing the Safety and Regulatory Oversight of Unapproved Medicinal Cannabis Products consultation commenced on 11 August 2025 and will close on 7 October.
tga
The Therapeutic Goods Administration (TGA) has taken action against the unlawful advertising of medicinal cannabis, issuing 35 infringement notices totaling $627,252 to six businesses and two individuals. The penalties were imposed for alleged violations in advertising medicinal cannabis on websites and social media platforms. Botanic Wellness Limited received the
2023
Here's my list of Australian cannabis predictions for 2023. Make of them what you will, and in a year we'll re-visit and see how many (if any) of them are correct.
ASX:MXC
The Australian Therapeutic Goods Administration has issued 73 infringement notices worth $972,360 to 3 licensed medical cannabis companies.
foliumed
"This limits access to medical cannabis to the well-heeled or those willing to take the risk to buy more cheaply from the black market,"
tga
TGA approvals for the month of January were down from 11,339 in December to 8785.
tga
Key stats include: ODC has granted 175 licenses (155 are in effect). 67 licenses (and 53 permits) for cultivation 31 for cultivation and research 57 for manufacture of medicinal cannabis products Over 100,000 patients and 160,000 authorisations.
tga
"The Therapeutic Goods Administration (TGA) is warning consumers about the risks of buying medicinal cannabis products online. Medicinal cannabis products bought online may be unsafe, of poor quality or contain a different dose to what the label claims."
tga
The TGA announced today that total medical cannabis approvals had hit 100,000 with 9959 being recorded for March 2021.
tga
Up to 28 February 2021, the TGA has approved over 99,000 SAS Category B applications for unapproved medicinal cannabis products.